Sheaff Brock Investment Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15,000	Closed	-$694K	–	459
2020 Q1	$694K	Hold	15,000	–	–	0.09%	136
2019 Q4	$926K	Hold	15,000	–	–	0.09%	155
2019 Q3	$638K	Hold	15,000	–	–	0.07%	201
2019 Q2	$778K	Hold	15,000	–	–	0.08%	180
2019 Q1	$832K	Hold	15,000	–	–	0.1%	164
2018 Q4	$631K	Buy	15,000 +5,000	+50%	+$261K	0.1%	193
2018 Q3	$697K	Hold	10,000	–	–	0.07%	208
2018 Q2	$572K	Hold	10,000	–	–	0.06%	233
2018 Q1	$551K	Hold	10,000	–	–	0.06%	237
2017 Q4	$561K	Sell	10,000 -125	-1%	-$7.05K	0.07%	236
2017 Q3	$620K	Sell	10,125 -50	-0.5%	-$2.84K	0.08%	222
2017 Q2	$543K	Buy	10,175 +175	+2%	+$8.54K	0.07%	260
2017 Q1	$483K	Hold	10,000	–	–	0.06%	289
2016 Q4	$399K	Hold	10,000	–	–	0.05%	322
2016 Q3	$485K	Hold	10,000	–	–	0.06%	273
2016 Q2	$388K	Sell	10,000 -1,100	-10%	-$47.4K	0.05%	323
2016 Q1	$454K	Hold	11,100	–	–	0.06%	306
2015 Q4	$794K	Buy	+11,100	New	+$742K	0.09%	223

Other funds holding BIB

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Sheaff Brock Investment Advisors's BIB Position: Q2 2020 in Review

Sheaff Brock Investment Advisors sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2020, closing a stake of 15,000 shares — an estimated $694K sold.

Sheaff Brock Investment Advisors first reported a position in BIB in Q4 2015 and held it in 18 quarters. The position peaked at $926K in Q4 2019. 27 funds tracked by Wall St. Rank hold BIB as of Q2 2020.

Sheaff Brock Investment Advisors reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2020 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 15,000 ProShares Ultra NASDAQ Biotechnology shares in Q2 2020, an estimated $694K.
Sheaff Brock Investment Advisors first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2015 and held it in 18 quarters.
Sheaff Brock Investment Advisors's ProShares Ultra NASDAQ Biotechnology position peaked at $926K in Q4 2019.
27 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2020.

Based on Sheaff Brock Investment Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.